Pathogenesis and potential reversibility of intestinal metaplasia − a milestone in gastric carcinogenesis

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394–424. doi: 10.3322/caac.21492 BrayF FerlayJ SoerjomataramI SiegelRL TorreLA JemalA Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 2018 68 394 424 10.3322/caac.21492 Open DOISearch in Google Scholar

2. de Brito BB, da Silva FAF, Soares AS, Pereira VA, Santos MLC, Sampaio MM, et al. Pathogenesis and clinical management of Helicobacter pylori gastric infection. World J Gastroenterol 2019; 25: 5578–89. doi: 10.3748/wjg.v25.i37.5578 de BritoBB da SilvaFAF SoaresAS PereiraVA SantosMLC SampaioMM Pathogenesis and clinical management of Helicobacter pylori gastric infection World J Gastroenterol 2019 25 5578 89 10.3748/wjg.v25.i37.5578 Open DOISearch in Google Scholar

3. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process − First American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52: 6735–40. PMID: 1458460 CorreaP Human gastric carcinogenesis: a multistep and multifactorial process − First American Cancer Society award lecture on cancer epidemiology and prevention Cancer Res 1992 52 6735 40 1458460 Search in Google Scholar

4. Kapadia CR. Gastric atrophy, metaplasia, and dysplasia: a clinical perspective. J Clin Gastroenterol 2003; 36: S29–36; discussion S61–62. doi: 10.1097/00004836-200305001-00006 KapadiaCR Gastric atrophy, metaplasia, and dysplasia: a clinical perspective J Clin Gastroenterol 2003 36 S29 36 discussion S61–62 10.1097/00004836-200305001-00006 Open DOISearch in Google Scholar

5. Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 1999; 94: 2373–9. doi: 10.1111/j.1572-0241.1999.01360.x EslickGD LimLL BylesJE XiaHH TalleyNJ Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis Am J Gastroenterol 1999 94 2373 9 10.1111/j.1572-0241.1999.01360.x Open DOISearch in Google Scholar

6. Rokkas T, Rokka A, Portincasa P. A systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer. Ann Gastroenterol 2017; 30: 414–23. doi: 10.20524/aog.2017.0144 RokkasT RokkaA PortincasaP A systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer Ann Gastroenterol 2017 30 414 23 10.20524/aog.2017.0144 Open DOISearch in Google Scholar

7. Wong BC-Y, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187–94. doi: 10.1001/jama.291.2.187 WongBC-Y LamSK WongWM ChenJS ZhengTT FengRE China Gastric Cancer Study Group Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial JAMA 2004 291 187 94 10.1001/jama.291.2.187 Open DOISearch in Google Scholar

8. Chen H-N, Wang Z, Li X, Zhou Z-G. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis. Gastric Cancer 2016; 19: 166–75. doi: 10.1007/s10120-015-0462-7 ChenH-N WangZ LiX ZhouZ-G Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis Gastric Cancer 2016 19 166 75 10.1007/s10120-015-0462-7 Open DOISearch in Google Scholar

9. Hwang Y-J, Kim N, Lee HS, Lee JB, Choi YJ, Yoon H, et al. Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication − a prospective study for up to 10 years. Aliment Pharmacol Ther 2018; 47: 380–90. doi: 10.1111/apt.14424 HwangY-J KimN LeeHS LeeJB ChoiYJ YoonH Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication − a prospective study for up to 10 years Aliment Pharmacol Ther 2018 47 380 90 10.1111/apt.14424 Open DOISearch in Google Scholar

10. Kodama M, Murakami K, Okimoto T, Sato R, Uchida M, Abe T, et al. Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication. J Gastroenterol 2012; 47: 394–403. doi: 10.1007/s00535-011-0504-9 KodamaM MurakamiK OkimotoT SatoR UchidaM AbeT Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication J Gastroenterol 2012 47 394 403 10.1007/s00535-011-0504-9 Open DOISearch in Google Scholar

11. Mišak Z, Hojsak I, Homan M. Review: Helicobacter pylori in pediatrics. Helicobacter 2019; 24 (Suppl 1): e12639. doi: 10.1111/hel.12639 MišakZ HojsakI HomanM Review: Helicobacter pylori in pediatrics Helicobacter 2019 24 Suppl 1 e12639 10.1111/hel.12639 Open DOISearch in Google Scholar

12. Goh K-L, Chan W-K, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 2011; 16 (Suppl 1): 1–9. doi: 10.1111/j.1523-5378.2011.00874.x GohK-L ChanW-K ShiotaS YamaokaY Epidemiology of Helicobacter pylori infection and public health implications Helicobacter 2011 16 Suppl 1 1 9 10.1111/j.1523-5378.2011.00874.x Open DOISearch in Google Scholar

13. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127–31. doi: 10.1056/NEJM199110173251603 ParsonnetJ FriedmanGD VandersteenDP ChangY VogelmanJH OrentreichN Helicobacter pylori infection and the risk of gastric carcinoma N Engl J Med 1991 325 1127 31 10.1056/NEJM199110173251603 Open DOISearch in Google Scholar

14. Hansson LR, Engstrand L, Nyrén O, Lindgren A. Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology 1995; 109: 885–8. doi: 10.1016/0016-5085(95)90398-4 HanssonLR EngstrandL NyrénO LindgrenA Prevalence of Helicobacter pylori infection in subtypes of gastric cancer Gastroenterology 1995 109 885 8 10.1016/0016-5085(95)90398-4 Open DOISearch in Google Scholar

15. Ansari S, Gantuya B, Tuan VP, Yamaoka Y. Diffuse gastric cancer: a summary of analogous contributing factors for its molecular pathogenicity. Int J Mol Sci 2018; 19: 2424. doi: 10.3390/ijms19082424 AnsariS GantuyaB TuanVP YamaokaY Diffuse gastric cancer: a summary of analogous contributing factors for its molecular pathogenicity Int J Mol Sci 2018 19 2424 10.3390/ijms19082424 Open DOISearch in Google Scholar

16. Correa P, Haenszel W, Cuello C, Zavala D, Fontham E, Zarama G, et al. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res 1990; 50: 4737–40. CorreaP HaenszelW CuelloC ZavalaD FonthamE ZaramaG Gastric precancerous process in a high risk population: cohort follow-up Cancer Res 1990 50 4737 40 Search in Google Scholar

17. Park YH, Kim N. Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev 2015; 20: 25–40. doi: 10.15430/JCP.2015.20.1.25 ParkYH KimN Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer J Cancer Prev 2015 20 25 40 10.15430/JCP.2015.20.1.25 Open DOISearch in Google Scholar

18. Pimentel-Nunes P, Libânio D, Marcos-Pinto R, Areia M, Leja M, Esposito G, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy 2019; 51: 365–88. doi: 10.1055/a-0859-1883 Pimentel-NunesP LibânioD Marcos-PintoR AreiaM LejaM EspositoG Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019 Endoscopy 2019 51 365 88 10.1055/a-0859-1883 Open DOISearch in Google Scholar

19. Šterbenc A, Jarc E, Poljak M, Homan M. Helicobacter pylori virulence genes. World J Gastroenterol 2019; 25: 4870–884. doi: 10.3748/wjg.v25.i33.4870 ŠterbencA JarcE PoljakM HomanM Helicobacter pylori virulence genes World J Gastroenterol 2019 25 4870 884 10.3748/wjg.v25.i33.4870 Open DOISearch in Google Scholar

20. Höcker M, Hohenberger P. Helicobacter pylori virulence factors − one part of a big picture. Lancet 2003; 362: 1231–3. doi: 10.1016/S0140-6736(03)14547-3 HöckerM HohenbergerP Helicobacter pylori virulence factors − one part of a big picture Lancet 2003 362 1231 3 10.1016/S0140-6736(03)14547-3 Open DOISearch in Google Scholar

21. Šterbenc A, Lunar MM, Homan M, Luzar B, Zidar N, Poljak M. Prevalence of the Helicobacter pylori babA2 gene in children mainly depends on the PCR primer set used. Can J Infect Dis Med Microbiol 2020; 2020: 4080248. doi: 10.1155/2020/4080248 ŠterbencA LunarMM HomanM LuzarB ZidarN PoljakM Prevalence of the Helicobacter pylori babA2 gene in children mainly depends on the PCR primer set used Can J Infect Dis Med Microbiol 2020 2020 4080248 10.1155/2020/4080248 Open DOISearch in Google Scholar

22. Mobley HL, Island MD, Hausinger RP. Molecular biology of microbial ureases. Microbiol Rev 1995; 59: 451–80. doi: 10.1128/mr.59.3.451-480.1995 MobleyHL IslandMD HausingerRP Molecular biology of microbial ureases Microbiol Rev 1995 59 451 80 10.1128/mr.59.3.451-480.1995 Open DOISearch in Google Scholar

23. Schwartz JT, Allen L-AH. Role of urease in megasome formation and Helicobacter pylori survival in macrophages. J Leukoc Biol 2006; 79: 1214–25. doi: 10.1189/jlb.0106030 SchwartzJT AllenL-AH Role of urease in megasome formation and Helicobacter pylori survival in macrophages J Leukoc Biol 2006 79 1214 25 10.1189/jlb.0106030 Open DOISearch in Google Scholar

24. Eaton KA, Suerbaum S, Josenhans C, Krakowka S. Colonization of gnotobiotic piglets by Helicobacter pylori deficient in two flagellin genes. Infect Immun 1996; 64: 2445–8. doi: 10.1128/iai.64.7.2445-2448.1996 EatonKA SuerbaumS JosenhansC KrakowkaS Colonization of gnotobiotic piglets by Helicobacter pylori deficient in two flagellin genes Infect Immun 1996 64 2445 8 10.1128/iai.64.7.2445-2448.1996 Open DOISearch in Google Scholar

25. Kim JS, Chang JH, Chung SI, Yum JS. Molecular cloning and characterization of the Helicobacter pylori fliD gene, an essential factor in flagellar structure and motility. J Bacteriol 1999; 181: 6969–76. doi: 10.1128/JB.181.22.6969-6976.1999 KimJS ChangJH ChungSI YumJS Molecular cloning and characterization of the Helicobacter pylori fliD gene, an essential factor in flagellar structure and motility J Bacteriol 1999 181 6969 76 10.1128/JB.181.22.6969-6976.1999 Open DOISearch in Google Scholar

26. Howitt MR, Lee JY, Lertsethtakarn P, Vogelmann R, Joubert L-M, Ottemann KM, et al. ChePep controls Helicobacter pylori infection of the gastric glands and chemotaxis in the Epsilonproteobacteria. mBio 2011; 2: e00098–11. doi: 10.1128/mBio.00098-11 HowittMR LeeJY LertsethtakarnP VogelmannR JoubertL-M OttemannKM ChePep controls Helicobacter pylori infection of the gastric glands and chemotaxis in the Epsilonproteobacteria mBio 2011 2 e00098 11 10.1128/mBio.00098-11 Open DOISearch in Google Scholar

27. Kao CY, Sheu BS, Sheu SM, Yang HB, Chang WL, Cheng HC, et al. Higher motility enhances bacterial density and inflammatory response in dyspeptic patients infected with Helicobacter pylori. Helicobacter 2012; 17: 411–6. doi: 10.1111/j.1523-5378.2012.00974.x KaoCY SheuBS SheuSM YangHB ChangWL ChengHC Higher motility enhances bacterial density and inflammatory response in dyspeptic patients infected with Helicobacter pylori Helicobacter 2012 17 411 6 10.1111/j.1523-5378.2012.00974.x Open DOISearch in Google Scholar

28. Lertsethtakarn P, Ottemann KM, Hendrixson DR. Motility and chemotaxis in Campylobacter and Helicobacter. Annu Rev Microbiol 2011; 65: 389–410. doi: 10.1146/annurev-micro-090110-102908 LertsethtakarnP OttemannKM HendrixsonDR Motility and chemotaxis in Campylobacter and Helicobacter Annu Rev Microbiol 2011 65 389 410 10.1146/annurev-micro-090110-102908 Open DOISearch in Google Scholar

29. Tian W, Jia Y, Yuan K, Huang L, Nadolny C, Dong X, et al. Serum antibody against Helicobacter pylori FlaA and risk of gastric cancer. Helicobacter 2014; 19: 9–16. doi: 10.1111/hel.12095 TianW JiaY YuanK HuangL NadolnyC DongX Serum antibody against Helicobacter pylori FlaA and risk of gastric cancer Helicobacter 2014 19 9 16 10.1111/hel.12095 Open DOISearch in Google Scholar

30. Toyoshima O, Nishizawa T, Sakitani K, Yamakawa T, Takahashi Y, Yamamichi N, et al. Serum anti-Helicobacter pylori antibody titer and its association with gastric nodularity, atrophy, and age: a cross-sectional study. World J Gastroenterol 2018; 24: 4061–8. doi: 10.3748/wjg.v24.i35.4061 ToyoshimaO NishizawaT SakitaniK YamakawaT TakahashiY YamamichiN Serum anti-Helicobacter pylori antibody titer and its association with gastric nodularity, atrophy, and age: a cross-sectional study World J Gastroenterol 2018 24 4061 8 10.3748/wjg.v24.i35.4061 Open DOISearch in Google Scholar

31. Yamaoka Y. Roles of Helicobacter pylori BabA in gastroduodenal pathogenesis. World J Gastroenterol 2008; 14: 4265–72. doi: 10.3748/wjg.14.4265 YamaokaY Roles of Helicobacter pylori BabA in gastroduodenal pathogenesis World J Gastroenterol 2008 14 4265 72 10.3748/wjg.14.4265 Open DOISearch in Google Scholar

32. Backert S, Clyne M, Tegtmeyer N. Molecular mechanisms of gastric epithelial cell adhesion and injection of CagA by Helicobacter pylori. Cell Commun Signal 2011; 9: 28. doi: 10.1186/1478-811X-9-28 BackertS ClyneM TegtmeyerN Molecular mechanisms of gastric epithelial cell adhesion and injection of CagA by Helicobacter pylori Cell Commun Signal 2011 9 28 10.1186/1478-811X-9-28 Open DOISearch in Google Scholar

33. Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET, et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998; 279: 373–7. doi: 10.1126/science.279.5349.373 IlverD ArnqvistA OgrenJ FrickIM KersulyteD IncecikET Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging Science 1998 279 373 7 10.1126/science.279.5349.373 Open DOISearch in Google Scholar

34. Gerhard M, Lehn N, Neumayer N, Borén T, Rad R, Schepp W, et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. PNAS 1999; 96: 12778–83. doi: 10.1073/pnas.96.22.12778 GerhardM LehnN NeumayerN BorénT RadR ScheppW Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin PNAS 1999 96 12778 83 10.1073/pnas.96.22.12778 Open DOISearch in Google Scholar

35. Oleastro M, Gerhard M, Lopes AI, Ramalho P, Cabral J, Sousa Guerreiro A, et al. Helicobacter pylori virulence genotypes in Portuguese children and adults with gastroduodenal pathology. Eur J Clin Microbiol Infect Dis 2003; 22: 85–91. doi: 10.1007/s10096-002-0865-3 OleastroM GerhardM LopesAI RamalhoP CabralJ Sousa GuerreiroA Helicobacter pylori virulence genotypes in Portuguese children and adults with gastroduodenal pathology Eur J Clin Microbiol Infect Dis 2003 22 85 91 10.1007/s10096-002-0865-3 Open DOISearch in Google Scholar

36. Olfat FO, Zheng Q, Oleastro M, Voland P, Borén T, Karttunen R, et al. Correlation of the Helicobacter pylori adherence factor BabA with duodenal ulcer disease in four European countries. FEMS Immunol Med Microbiol 2005; 44: 151–6. doi: 10.1016/j.femsim.2004.10.010 OlfatFO ZhengQ OleastroM VolandP BorénT KarttunenR Correlation of the Helicobacter pylori adherence factor BabA with duodenal ulcer disease in four European countries FEMS Immunol Med Microbiol 2005 44 151 6 10.1016/j.femsim.2004.10.010 Open DOISearch in Google Scholar

37. Oliveira AG, Santos A, Guerra JB, Rocha GA, Rocha AMC, Oliveira CA, et al. babA2- and cagA-positive Helicobacter pylori strains are associated with duodenal ulcer and gastric carcinoma in Brazil. J Clin Microbiol 2003; 41: 3964–6. doi: 10.1128/jcm.41.8.3964-3966.2003 OliveiraAG SantosA GuerraJB RochaGA RochaAMC OliveiraCA babA2- and cagA-positive Helicobacter pylori strains are associated with duodenal ulcer and gastric carcinoma in Brazil J Clin Microbiol 2003 41 3964 6 10.1128/jcm.41.8.3964-3966.2003 Open DOISearch in Google Scholar

38. Abadi ATB, Rafiei A, Ajami A, Hosseini V, Taghvaei T, Jones KR, et al. Helicobacter pylori homB, but not cagA, is associated with gastric cancer in Iran. J Clin Microbiol 2011; 49: 3191–7. doi: 10.1128/JCM.00947-11 AbadiATB RafieiA AjamiA HosseiniV TaghvaeiT JonesKR Helicobacter pylori homB, but not cagA, is associated with gastric cancer in Iran J Clin Microbiol 2011 49 3191 7 10.1128/JCM.00947-11 Open DOISearch in Google Scholar

39. Šterbenc A, Poljak M, Zidar N, Luzar B, Homan M. Prevalence of the Helicobacter pylori homA and homB genes and their correlation with histological parameters in children. Microb Pathog 2018; 125: 26–32. doi: 10.1016/j.micpath.2018.09.005 ŠterbencA PoljakM ZidarN LuzarB HomanM Prevalence of the Helicobacter pylori homA and homB genes and their correlation with histological parameters in children Microb Pathog 2018 125 26 32 10.1016/j.micpath.2018.09.005 Open DOISearch in Google Scholar

40. Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T, et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A 2002; 99: 14428–33. doi: 10.1073/pnas.222375399 HigashiH TsutsumiR FujitaA YamazakiS AsakaM AzumaT Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites Proc Natl Acad Sci U S A 2002 99 14428 33 10.1073/pnas.222375399 Open DOISearch in Google Scholar

41. Yamazaki S, Yamakawa A, Ito Y, Ohtani M, Higashi H, Hatakeyama M, et al. The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. J Infect Dis 2003; 187: 334–7. doi: 10.1086/367807 YamazakiS YamakawaA ItoY OhtaniM HigashiH HatakeyamaM The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa J Infect Dis 2003 187 334 7 10.1086/367807 Open DOISearch in Google Scholar

42. Kikuchi K, Murata-Kamiya N, Kondo S, Hatakeyama M. Helicobacter pylori stimulates epithelial cell migration via CagA-mediated perturbation of host cell signaling. Microbes Infect 2012; 14: 470–6. doi: 10.1016/j.micinf.2011.12.003 KikuchiK Murata-KamiyaN KondoS HatakeyamaM Helicobacter pylori stimulates epithelial cell migration via CagA-mediated perturbation of host cell signaling Microbes Infect 2012 14 470 6 10.1016/j.micinf.2011.12.003 Open DOISearch in Google Scholar

43. Boonyanugomol W, Chomvarin C, Hahnvajanawong C, Sripa B, Kaparakis-Liaskos M, Ferrero RL. Helicobacter pylori cag pathogenicity island (cag-PAI) Involved in bacterial internalization and IL-8 induced responses via NOD1- and MyD88-dependent mechanisms in human biliary epithelial cells. PLoS One 2013; 8: e77358. doi: 10.1371/journal.pone.0077358 BoonyanugomolW ChomvarinC HahnvajanawongC SripaB Kaparakis-LiaskosM FerreroRL Helicobacter pylori cag pathogenicity island (cag-PAI) Involved in bacterial internalization and IL-8 induced responses via NOD1- and MyD88-dependent mechanisms in human biliary epithelial cells PLoS One 2013 8 e77358 10.1371/journal.pone.0077358 Open DOISearch in Google Scholar

44. Bentires-Alj M, Paez JG, David FS, Keilhack H, Halmos B, Naoki K, et al. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res 2004; 64: 8816–20. doi: 10.1158/0008-5472.CAN-04-1923 Bentires-AljM PaezJG DavidFS KeilhackH HalmosB NaokiK Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia Cancer Res 2004 64 8816 20 10.1158/0008-5472.CAN-04-1923 Open DOISearch in Google Scholar

45. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 2004; 4: 688–94. doi: 10.1038/nrc1433 HatakeyamaM Oncogenic mechanisms of the Helicobacter pylori CagA protein Nat Rev Cancer 2004 4 688 94 10.1038/nrc1433 Open DOISearch in Google Scholar

46. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A 1996; 93: 14648–53. doi: 10.1073/pnas.93.25.14648 CensiniS LangeC XiangZ CrabtreeJE GhiaraP BorodovskyM cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors Proc Natl Acad Sci U S A 1996 93 14648 53 10.1073/pnas.93.25.14648 Open DOISearch in Google Scholar

47. Homan M, Luzar B, Kocjan BJ, Orel R, Mocilnik T, Shrestha M, et al. Prevalence and clinical relevance of cagA, vacA, and iceA genotypes of Helicobacter pylori isolated from Slovenian children. J Pediatr Gastroenterol Nutr 2009; 49: 289–96. doi: 10.1097/MPG.0b013e31818f09f2 HomanM LuzarB KocjanBJ OrelR MocilnikT ShresthaM Prevalence and clinical relevance of cagA, vacA, and iceA genotypes of Helicobacter pylori isolated from Slovenian children J Pediatr Gastroenterol Nutr 2009 49 289 96 10.1097/MPG.0b013e31818f09f2 Open DOISearch in Google Scholar

48. Chiurillo MA, Moran Y, Cañas M, Valderrama E, Granda N, Sayegh M, et al. Genotyping of Helicobacter pylori virulence-associated genes shows high diversity of strains infecting patients in western Venezuela. Int J Infect Dis 2013; 17: e750–6.doi: 10.1016/j.ijid.2013.03.004 ChiurilloMA MoranY CañasM ValderramaE GrandaN SayeghM Genotyping of Helicobacter pylori virulence-associated genes shows high diversity of strains infecting patients in western Venezuela Int J Infect Dis 2013 17 e750 6 10.1016/j.ijid.2013.03.004 Open DOISearch in Google Scholar

49. Homan M, Hojsak I, Kolaček S. Helicobacter pylori in pediatrics. Helicobacter 2012; 17 (Suppl 1): 43–8. doi: 10.1111/j.1523-5378.2012.00982.x HomanM HojsakI KolačekS Helicobacter pylori in pediatrics Helicobacter 2012 17 Suppl 1 43 8 10.1111/j.1523-5378.2012.00982.x Open DOISearch in Google Scholar

50. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 1999; 37: 2274–9. doi: 10.1128/JCM.37.7.2274-2279.1999 YamaokaY KodamaT GutierrezO KimJG KashimaK GrahamDY Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries J Clin Microbiol 1999 37 2274 9 10.1128/JCM.37.7.2274-2279.1999 Open DOISearch in Google Scholar

51. Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, Atherton JC. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 2004; 127: 514–23. doi: 10.1053/j.gastro.2004.06.006 ArgentRH KiddM OwenRJ ThomasRJ LimbMC AthertonJC Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori Gastroenterology 2004 127 514 23 10.1053/j.gastro.2004.06.006 Open DOISearch in Google Scholar

52. Palframan SL, Kwok T, Gabriel K. Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis. Front Cell Infect Microbiol 2012; 2: 92. doi: 10.3389/fcimb.2012.00092 PalframanSL KwokT GabrielK Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis Front Cell Infect Microbiol 2012 2 92 10.3389/fcimb.2012.00092 Open DOISearch in Google Scholar

53. Hisatsune J, Nakayama M, Isomoto H, Kurazono H, Mukaida N, Mukhopadhyay AK, et al. Molecular characterization of Helicobacter pylori VacA induction of IL-8 in U937 cells reveals a prominent role for p38MAPK in activating transcription factor-2, cAMP response element binding protein, and NF-kappaB activation. J Immunol 2008; 180: 5017–27. doi: 10.4049/jimmunol.180.7.5017 HisatsuneJ NakayamaM IsomotoH KurazonoH MukaidaN MukhopadhyayAK Molecular characterization of Helicobacter pylori VacA induction of IL-8 in U937 cells reveals a prominent role for p38MAPK in activating transcription factor-2, cAMP response element binding protein, and NF-kappaB activation J Immunol 2008 180 5017 27 10.4049/jimmunol.180.7.5017 Open DOISearch in Google Scholar

54. Atherton JC, Cao P, Peek RM, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 17771–7. doi: 10.1074/jbc.270.30.17771 AthertonJC CaoP PeekRM TummuruMK BlaserMJ CoverTL Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration J Biol Chem 1995 270 17771 7 10.1074/jbc.270.30.17771 Open DOISearch in Google Scholar

55. Abdi E, Latifi-Navid S, Latifi-Navid H, Safarnejad B. Helicobacter pylori vacuolating cytotoxin genotypes and preneoplastic lesions or gastric cancer risk: a meta-analysis. J Gastroenterol Hepatol 2016; 31: 734–44. doi: 10.1111/jgh.13256 AbdiE Latifi-NavidS Latifi-NavidH SafarnejadB Helicobacter pylori vacuolating cytotoxin genotypes and preneoplastic lesions or gastric cancer risk: a meta-analysis J Gastroenterol Hepatol 2016 31 734 44 10.1111/jgh.13256 Open DOISearch in Google Scholar

56. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161–81. doi: 10.1097/00000478-199610000-00001 DixonMF GentaRM YardleyJH CorreaP Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994 Am J Surg Pathol 1996 20 1161 81 10.1097/00000478-199610000-00001 Open DOISearch in Google Scholar

57. Mutoh H, Sakurai S, Satoh K, Osawa H, Tomiyama T, Kita H et al. Pericryptal fibroblast sheath in intestinal metaplasia and gastric carcinoma. Gut 2005; 54: 33–9. doi: 10.1136/gut.2004.042770 MutohH SakuraiS SatohK OsawaH TomiyamaT KitaH Pericryptal fibroblast sheath in intestinal metaplasia and gastric carcinoma Gut 2005 54 33 9 10.1136/gut.2004.042770 Open DOISearch in Google Scholar

58. Reis CA, David L, Correa P, Carneiro F, de Bolós C, Garcia E, et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 1999; 59: 1003–7. PMID: 10070955 ReisCA DavidL CorreaP CarneiroF de BolósC GarciaE Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression Cancer Res 1999 59 1003 7 10070955 Search in Google Scholar

59. Capelle LG, de Vries AC, Haringsma J, Ter Borg F, de Vries RA, Bruno MJ, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010; 71: 1150–8. doi: 10.1016/j.gie.2009.12.029 CapelleLG de VriesAC HaringsmaJ Ter BorgF de VriesRA BrunoMJ The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis Gastrointest Endosc 2010 71 1150 8 10.1016/j.gie.2009.12.029 Open DOISearch in Google Scholar

60. Lim JH, Kim N, Lee HS, Choe G, Jo SY, Chon I, et al. Correlation between endoscopic and histological diagnoses of gastric intestinal metaplasia. Gut Liver 2013; 7: 41–50. doi: 10.5009/gnl.2013.7.1.41 LimJH KimN LeeHS ChoeG JoSY ChonI Correlation between endoscopic and histological diagnoses of gastric intestinal metaplasia Gut Liver 2013 7 41 50 10.5009/gnl.2013.7.1.41 Open DOISearch in Google Scholar

61. Marques-Silva L, Areia M, Elvas L, Dinis-Ribeiro M. Prevalence of gastric precancerous conditions: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2014; 26: 378–87. doi: 10.1097/MEG.0000000000000065 Marques-SilvaL AreiaM ElvasL Dinis-RibeiroM Prevalence of gastric precancerous conditions: a systematic review and meta-analysis Eur J Gastroenterol Hepatol 2014 26 378 87 10.1097/MEG.0000000000000065 Open DOISearch in Google Scholar

62. Song H, Ekheden IG, Zheng Z, Ericsson J, Nyrén O, Ye W. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ 2015; 351: h3867. doi: 10.1136/bmj.h3867 SongH EkhedenIG ZhengZ EricssonJ NyrénO YeW Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population BMJ 2015 351 h3867 10.1136/bmj.h3867 Open DOISearch in Google Scholar

63. Huang RJ, Choi AY, Truong CD, Yeh MM, Hwang JH. Diagnosis and management of gastric intestinal metaplasia: current status and future directions. Gut Liver 2019; 13: 596–603. doi: 10.5009/gnl19181 HuangRJ ChoiAY TruongCD YehMM HwangJH Diagnosis and management of gastric intestinal metaplasia: current status and future directions Gut Liver 2019 13 596 603 10.5009/gnl19181 Open DOISearch in Google Scholar

64. González CA, Sanz-Anquela JM, Gisbert JP, Correa P. Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence. Int J Cancer 2013; 133: 1023–32. doi: 10.1002/ijc.28003 GonzálezCA Sanz-AnquelaJM GisbertJP CorreaP Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence Int J Cancer 2013 133 1023 32 10.1002/ijc.28003 Open DOISearch in Google Scholar

65. Gupta S, Tao L, Murphy JD, Camargo MC, Oren E, Valasek MA, et al. Race/ethnicity-, socioeconomic status-, and anatomic subsite-specific risks for gastric cancer. Gastroenterology 2019; 156: 59–62.e4. doi: 10.1053/j.gastro.2018.09.045 GuptaS TaoL MurphyJD CamargoMC OrenE ValasekMA Race/ethnicity-, socioeconomic status-, and anatomic subsite-specific risks for gastric cancer Gastroenterology 2019 156 59 62.e4 10.1053/j.gastro.2018.09.045 Open DOISearch in Google Scholar

66. Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002; 11: 235–56. doi: 10.1016/s1055-3207(02)00002-9 BrownLM DevesaSS Epidemiologic trends in esophageal and gastric cancer in the United States Surg Oncol Clin N Am 2002 11 235 56 10.1016/s1055-3207(02)00002-9 Open DOISearch in Google Scholar

67. Derakhshan MH, Liptrot S, Paul J, Brown IL, Morrison D, McColl KEL. Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females. Gut 2009; 58: 16–23. doi: 10.1136/gut.2008.161331 DerakhshanMH LiptrotS PaulJ BrownIL MorrisonD McCollKEL Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females Gut 2009 58 16 23 10.1136/gut.2008.161331 Open DOISearch in Google Scholar

68. Edgren G, Hjalgrim H, Rostgaard K, Norda R, Wikman A, Melbye M, et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol 2010; 172: 1280–5. doi: 10.1093/aje/kwq299 EdgrenG HjalgrimH RostgaardK NordaR WikmanA MelbyeM Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study Am J Epidemiol 2010 172 1280 5 10.1093/aje/kwq299 Open DOISearch in Google Scholar

69. Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M et al. SEER cancer statistics review, 1975–2016, National Cancer Institute. Bethesda, MD. Available at: https://seer.cancer.gov/csr/1975_2016/, based on November 2018 SEER data submission, posted to the SEER web site, April 2019. Updated April 9, 2020. (cited 2021 Feb 22). HowladerN NooneAM KrapchoM MillerD BrestA YuMl SEER cancer statistics review, 1975–2016 National Cancer Institute Bethesda, MD Available at: https://seer.cancer.gov/csr/1975_2016/, based on November 2018 SEER data submission, posted to the SEER web site, April 2019. Updated April 9, 2020. (cited 2021 Feb 22). Search in Google Scholar

70. Trédaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A. Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer 1997; 72: 565–73. doi: 10.1002/(sici)1097-0215(19970807)72:4<565::aid-ijc3>3.0.co;2-o TrédanielJ BoffettaP BuiattiE SaracciR HirschA Tobacco smoking and gastric cancer: review and meta-analysis Int J Cancer 1997 72 565 73 10.1002/(sici)1097-0215(19970807)72:4<565::aid-ijc3>3.0.co;2-o Open DOISearch in Google Scholar

71. Kneller RW, You WC, Chang YS, Liu WD, Zhang L, Zhao L, et al. Cigarette smoking and other risk factors for progression of precancerous stomach lesions. J Natl Cancer Inst 1992; 84: 1261–6. doi: 10.1093/jnci/84.16.1261 KnellerRW YouWC ChangYS LiuWD ZhangL ZhaoL Cigarette smoking and other risk factors for progression of precancerous stomach lesions J Natl Cancer Inst 1992 84 1261 6 10.1093/jnci/84.16.1261 Open DOISearch in Google Scholar

72. Tatsugami M, Ito M, Tanaka S, Yoshihara M, Matsui H, Haruma K, et al. Bile acid promotes intestinal metaplasia and gastric carcinogenesis. Cancer Epidemiol Biomarkers Prev 2012; 21: 2101–7. doi: 10.1158/1055-9965.EPI-12-0730 TatsugamiM ItoM TanakaS YoshiharaM MatsuiH HarumaK Bile acid promotes intestinal metaplasia and gastric carcinogenesis Cancer Epidemiol Biomarkers Prev 2012 21 2101 7 10.1158/1055-9965.EPI-12-0730 Open DOISearch in Google Scholar

73. Li T, Guo H, Li H, Jiang Y, Zhuang K, Lei C, et al. MicroRNA-92a-1–5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasia. Gut 2019; 68: 1751–63. doi: 10.1136/gutjnl-2017-315318 LiT GuoH LiH JiangY ZhuangK LeiC MicroRNA-92a-1–5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasia Gut 2019 68 1751 63 10.1136/gutjnl-2017-315318 Open DOISearch in Google Scholar

74. Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H. Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res 2005; 589: 47–65. doi: 10.1016/j.mrrev.2004.08.001 BernsteinH BernsteinC PayneCM DvorakovaK GarewalH Bile acids as carcinogens in human gastrointestinal cancers Mutat Res 2005 589 47 65 10.1016/j.mrrev.2004.08.001 Open DOISearch in Google Scholar

75. Lee S-A, Kang D, Shim KN, Choe JW, Hong WS, Choi H. Effect of diet and Helicobacter pylori infection to the risk of early gastric cancer. J Epidemiol 2003; 13: 162–8. doi: 10.2188/jea.13.162 LeeS-A KangD ShimKN ChoeJW HongWS ChoiH Effect of diet and Helicobacter pylori infection to the risk of early gastric cancer J Epidemiol 2003 13 162 8 10.2188/jea.13.162 Open DOISearch in Google Scholar

76. Loh JT, Torres VJ, Cover TL. Regulation of Helicobacter pylori cagA expression in response to salt. Cancer Res 2007; 67: 4709–15. doi: 10.1158/0008-5472.CAN-06-4746 LohJT TorresVJ CoverTL Regulation of Helicobacter pylori cagA expression in response to salt Cancer Res 2007 67 4709 15 10.1158/0008-5472.CAN-06-4746 Open DOISearch in Google Scholar

77. Takahashi M, Nishikawa A, Furukawa F, Enami T, Hasegawa T, Hayashi Y. Dose-dependent promoting effects of sodium chloride (NaCl) on rat glandular stomach carcinogenesis initiated with N-methyl-N′-nitro-N-nitrosoguanidine. Carcinogenesis 1994; 15: 1429–32. doi: 10.1093/carcin/15.7.1429 TakahashiM NishikawaA FurukawaF EnamiT HasegawaT HayashiY Dose-dependent promoting effects of sodium chloride (NaCl) on rat glandular stomach carcinogenesis initiated with N-methyl-N′-nitro-N-nitrosoguanidine Carcinogenesis 1994 15 1429 32 10.1093/carcin/15.7.1429 Open DOISearch in Google Scholar

78. Cross AJ, Pollock JRA, Bingham SA. Haem, not protein or inorganic iron, is responsible for endogenous intestinal N-nitrosation arising from red meat. Cancer Res 2003; 63: 2358–60. CrossAJ PollockJRA BinghamSA Haem, not protein or inorganic iron, is responsible for endogenous intestinal N-nitrosation arising from red meat Cancer Res 2003 63 2358 60 Search in Google Scholar

79. Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc 2008; 67: 253–6. doi: 10.1017/S002966510800712X WisemanM The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective Proc Nutr Soc 2008 67 253 6 10.1017/S002966510800712X Open DOISearch in Google Scholar

80. Ta G, Yi K, Mc S, Mv G, W S, S M, et al. Folic acid increases global DNA methylation and reduces inflammation to prevent Helicobacter-associated gastric cancer in mice. Gastroenterology 2012; 142: 824–33.e7. doi: 10.1053/j.gastro.2011.12.058 GTa KYi SMc GMv SW MS Folic acid increases global DNA methylation and reduces inflammation to prevent Helicobacter-associated gastric cancer in mice Gastroenterology 2012 142 824 33.e7 10.1053/j.gastro.2011.12.058 Open DOISearch in Google Scholar

81. Yanaoka K, Oka M, Ohata H, Yoshimura N, Deguchi H, Mukoubayashi C et al. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels. Int J Cancer 2009; 125: 2697–703. doi: 10.1002/ijc.24591 YanaokaK OkaM OhataH YoshimuraN DeguchiH MukoubayashiCl Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels Int J Cancer 2009 125 2697 703 10.1002/ijc.24591 Open DOISearch in Google Scholar

82. Sung JJ, Lin SR, Ching JY, Zhou LY, To KF, Wang RT, et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 2000; 119: 7–14. doi: 10.1053/gast.2000.8550 SungJJ LinSR ChingJY ZhouLY ToKF WangRT Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study Gastroenterology 2000 119 7 14 10.1053/gast.2000.8550 Open DOISearch in Google Scholar

83. Kiriyama Y, Tahara T, Shibata T, Okubo M, Nakagawa M, Okabe A, et al. Gastric-and-intestinal mixed intestinal metaplasia is irreversible point with eradication of Helicobacter pylori. Open Journal of Pathology 2016; 6: 93–104. doi: 10.4236/ojpathology.2016.62012 KiriyamaY TaharaT ShibataT OkuboM NakagawaM OkabeA Gastric-and-intestinal mixed intestinal metaplasia is irreversible point with eradication of Helicobacter pylori Open Journal of Pathology 2016 6 93 104 10.4236/ojpathology.2016.62012 Open DOISearch in Google Scholar

84. Satoh K, Kimura K, Takimoto T, Kihira K. A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori. Helicobacter 1998; 3: 236–40. PMID: 9844064 SatohK KimuraK TakimotoT KihiraK A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori Helicobacter 1998 3 236 40 9844064 Search in Google Scholar

85. Kodama M, Okimoto T, Ogawa R, Mizukami K, Murakami K. Endoscopic atrophic classification before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia. Endosc Int Open 2015; 3: E311–7. doi: 10.1055/s-0034-1392090 KodamaM OkimotoT OgawaR MizukamiK MurakamiK Endoscopic atrophic classification before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia Endosc Int Open 2015 3 E311 7 10.1055/s-0034-1392090 Open DOISearch in Google Scholar

86. Lu B, Chen M-T, Fan Y-H, Liu Y, Meng L-N. Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: a 3-year follow-up study. World J Gastroenterol 2005; 11: 6518–20. doi: 10.3748/wjg.v11.i41.6518 LuB ChenM-T FanY-H LiuY MengL-N Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: a 3-year follow-up study World J Gastroenterol 2005 11 6518 20 10.3748/wjg.v11.i41.6518 Open DOISearch in Google Scholar

87. Zhou L, Sung JJY, Lin S, Jin Z, Ding S, Huang X, et al. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication. Chin Med J (Engl) 2003; 116: 11–4. PMID: 12667379 ZhouL SungJJY LinS JinZ DingS HuangX A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication Chin Med J (Engl) 2003 116 11 4 12667379 Search in Google Scholar

88. Lee Y-C, Chiang T-H, Chou C-K, Tu Y-K, Liao W-C, Wu M-S, et al. Association between helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology 2016; 150: 1113–24.e5. doi: 10.1053/j.gastro.2016.01.028 LeeY-C ChiangT-H ChouC-K TuY-K LiaoW-C WuM-S Association between helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis Gastroenterology 2016 150 1113 24.e5 10.1053/j.gastro.2016.01.028 Open DOISearch in Google Scholar

89. Akbari M, Tabrizi R, Kardeh S, Lankarani KB. Gastric cancer in patients with gastric atrophy and intestinal metaplasia: a systematic review and meta-analysis. PLoS One 2019; 14: e0219865. doi: 10.1371/journal.pone.0219865 AkbariM TabriziR KardehS LankaraniKB Gastric cancer in patients with gastric atrophy and intestinal metaplasia: a systematic review and meta-analysis PLoS One 2019 14 e0219865 10.1371/journal.pone.0219865 Open DOISearch in Google Scholar

90. Huang KK, Ramnarayanan K, Zhu F, Srivastava S, Xu C, Tan ALK, et al. Genomic and Epigenomic profiling of high-risk intestinal metaplasia reveals molecular determinants of progression to gastric cancer. Cancer Cell 2018; 33: 137–50.e5. doi: 10.1016/j.ccell.2017.11.018 HuangKK RamnarayananK ZhuF SrivastavaS XuC TanALK Genomic and Epigenomic profiling of high-risk intestinal metaplasia reveals molecular determinants of progression to gastric cancer Cancer Cell 2018 33 137 50.e5 10.1016/j.ccell.2017.11.018 Open DOISearch in Google Scholar

91. Crider KS, Yang TP, Berry RJ, Bailey LB. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate’s role. Adv Nutr 2012; 3: 21–38. doi: 10.3945/an.111.000992 CriderKS YangTP BerryRJ BaileyLB Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate’s role Adv Nutr 2012 3 21 38 10.3945/an.111.000992 Open DOISearch in Google Scholar

92. Zhu S, Mason J, Shi Y, Hu Y, Li R, Wahg M, et al. The effect of folic acid on the development of stomach and other gastrointestinal cancers. Chin Med J (Engl) 2003; 116: 15–9. PMID: 12667380 ZhuS MasonJ ShiY HuY LiR WahgM The effect of folic acid on the development of stomach and other gastrointestinal cancers Chin Med J (Engl) 2003 116 15 9 12667380 Search in Google Scholar

93. Lei J, Ren F, Li W, Guo X, Liu Q, Gao H, et al. Use of folic acid supplementation to halt and even reverse the progression of gastric precancerous conditions: a meta-analysis. BMC Gastroenterol 2022; 22: 370. doi: 10.1186/s12876-022-02390-y LeiJ RenF LiW GuoX LiuQ GaoH Use of folic acid supplementation to halt and even reverse the progression of gastric precancerous conditions: a meta-analysis BMC Gastroenterol 2022 22 370 10.1186/s12876-022-02390-y Open DOISearch in Google Scholar

94. Tan M, Jamali T, Nguyen TH, Galvan A, Sealock RJ, Khan A, et al. Race/ethnicity and birthplace as risk factors for gastric intestinal metaplasia in a multiethnic united states population. Am J Gastroenterol 2022; 117: 280–7. doi: 10.14309/ajg.0000000000001576 TanM JamaliT NguyenTH GalvanA SealockRJ KhanA Race/ethnicity and birthplace as risk factors for gastric intestinal metaplasia in a multiethnic united states population Am J Gastroenterol 2022 117 280 7 10.14309/ajg.0000000000001576 Open DOISearch in Google Scholar

95. Akpoigbe K, Culpepper-Morgan J, Nwankwo O, Genao A. Predicting gastric intestinal metaplasia in a high-risk population. Cureus 2022; 14: e31502. doi: 10.7759/cureus.31502 AkpoigbeK Culpepper-MorganJ NwankwoO GenaoA Predicting gastric intestinal metaplasia in a high-risk population Cureus 2022 14 e31502 10.7759/cureus.31502 Open DOISearch in Google Scholar

96. Aumpan N, Vilaichone Rk, Pornthisarn B, Chonprasertsuk S, Siramolpiwat S, et al. Predictors for regression and progression of intestinal metaplasia (IM): a large population-based study from low prevalence area of gastric cancer (IM-predictor trial). PLoS One 2021 16: e0255601. doi: 10.1371/journal.pone.0255601 AumpanN VilaichoneRk PornthisarnB ChonprasertsukS SiramolpiwatS Predictors for regression and progression of intestinal metaplasia (IM): a large population-based study from low prevalence area of gastric cancer (IM-predictor trial) PLoS One 2021 16 e0255601 10.1371/journal.pone.0255601 Open DOISearch in Google Scholar

97. Tan MC, Mallepally N, Liu Y, El-Serag HB, Thrift AP. Demographic and lifestyle risk factors for gastric intestinal metaplasia among US veterans. Am J Gastroenterol 2020; 115: 381–7. doi: 10.14309/ajg.0000000000000498 TanMC MallepallyN LiuY El-SeragHB ThriftAP Demographic and lifestyle risk factors for gastric intestinal metaplasia among US veterans Am J Gastroenterol 2020 115 381 7 10.14309/ajg.0000000000000498 Open DOISearch in Google Scholar

98. Aumpan N, Vilaichone RK, Nunanan P, Chonprasertsuk S, Siramolpiwat S, et al. Predictors for development of complete and incomplete intestinal metaplasia (IM) associated with H. pylori infection: a large-scale study from low prevalence area of gastric cancer (IM-HP trial). PLoS One 2020; 15: e0239434. doi: 10.1371/journal.pone.0239434 AumpanN VilaichoneRK NunananP ChonprasertsukS SiramolpiwatS Predictors for development of complete and incomplete intestinal metaplasia (IM) associated with H. pylori infection: a large-scale study from low prevalence area of gastric cancer (IM-HP trial) PLoS One 2020 15 e0239434 10.1371/journal.pone.0239434 Open DOISearch in Google Scholar

99. Leung WK, Ng EK, Chan WY, Auyeung AC, Chan KF, Lam CC, et al. Risk factors associated with the development of intestinal metaplasia in first-degree relatives of gastric cancer patients. Cancer Epidemiol Biomarkers Prev 2005; 14: 2982–86. doi: 10.1158/1055-9965.EPI-05-0181 LeungWK NgEK ChanWY AuyeungAC ChanKF LamCC Risk factors associated with the development of intestinal metaplasia in first-degree relatives of gastric cancer patients Cancer Epidemiol Biomarkers Prev 2005 14 2982 86 10.1158/1055-9965.EPI-05-0181 Open DOISearch in Google Scholar

100. Joo YE, Park HK, Myung DS, Baik GH, Shin JE, Seo GS, et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea. Gut Liver 2013; 7: 303–10. doi: 10.5009/gnl.2013.7.3.303 JooYE ParkHK MyungDS BaikGH ShinJE SeoGS Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea Gut Liver 2013 7 303 10 10.5009/gnl.2013.7.3.303 Open DOISearch in Google Scholar

101. Tatsuta M, Iishi H, Nakaizumi A, Okuda S, Taniguchi H, Hiyama T, et al. Fundal atrophic gastritis as a risk factor for gastric cancer. Int J Cancer 1993; 53: 70–4. doi: 10.1002/ijc.2910530114 TatsutaM IishiH NakaizumiA OkudaS TaniguchiH HiyamaT Fundal atrophic gastritis as a risk factor for gastric cancer Int J Cancer 1993 53 70 4 10.1002/ijc.2910530114 Open DOISearch in Google Scholar

102. Nguyen TH, Tan MC, Liu Y, Rugge M, Thrift AP, El-Serag HB. Prevalence of gastric intestinal metaplasia in a multiethnic US veterans’ population. Clin Gastroenterol Hepatol 2021; 19: 269–76. doi: 10.1016/j.cgh.2020.03.015 NguyenTH TanMC LiuY RuggeM ThriftAP El-SeragHB Prevalence of gastric intestinal metaplasia in a multiethnic US veterans’ population Clin Gastroenterol Hepatol 2021 19 269 76 10.1016/j.cgh.2020.03.015 Open DOISearch in Google Scholar

103. Nieuwenburg SAV, Mommersteeg MC, Eikenboom EL, Yu B, den Hollander WJ, Holster IL, et al. Factors associated with the progression of gastric intestinal metaplasia: a multicenter, prospective cohort study. Endosc Int Open 2021; 9: 297–305. doi: 10.1055/a-1314-6626 NieuwenburgSAV MommersteegMC EikenboomEL YuB den HollanderWJ HolsterIL Factors associated with the progression of gastric intestinal metaplasia: a multicenter, prospective cohort study Endosc Int Open 2021 9 297 305 10.1055/a-1314-6626 Open DOISearch in Google Scholar

104. Reddy KM, Chang JI, Shi JM, Wu BU. Risk of gastric cancer among patients with intestinal metaplasia of the stomach in a US integrated health care system. Clin Gastroenterol Hepatol 2016; 14: 1420–5. doi: 10.1016/j.cgh.2016.05.045 ReddyKM ChangJI ShiJM WuBU Risk of gastric cancer among patients with intestinal metaplasia of the stomach in a US integrated health care system Clin Gastroenterol Hepatol 2016 14 1420 5 10.1016/j.cgh.2016.05.045 Open DOISearch in Google Scholar

105. Holmes HM, Jove AG, Tan MC, El-Serag HB, Thrift AP. Alcohol consumption and the risk of gastric intestinal metaplasia in a U.S. Veterans population PLoS One 2021; 16: e0260019. doi: 10.1371/journal.pone.0260019. PMID: 34780551 HolmesHM JoveAG TanMC El-SeragHB ThriftAP Alcohol consumption and the risk of gastric intestinal metaplasia in a U.S. Veterans population PLoS One 2021 16 e0260019 10.1371/journal.pone.0260019 34780551 Open DOISearch in Google Scholar

106. Kim K, Chang Y, Ahn J, Yang HJ, Ryu S. Low levels of alcohol consumption and risk of intestinal metaplasia: a cohort study. Cancer Epidemiol Biomarkers Prev 2020; 29: 2633–41. doi: 10.1158/1055-9965.EPI-20-0858 KimK ChangY AhnJ YangHJ RyuS Low levels of alcohol consumption and risk of intestinal metaplasia: a cohort study Cancer Epidemiol Biomarkers Prev 2020 29 2633 41 10.1158/1055-9965.EPI-20-0858 Open DOISearch in Google Scholar

107. Morais S, Rodrigues S, Amorim L, Peleteiro B, Lunet N. Tobacco smoking and intestinal metaplasia: systematic review and meta-analysis. Dig Liver Dis 2014; 46: 1031–7. doi: 10.1016/j.dld.2014.08.034 MoraisS RodriguesS AmorimL PeleteiroB LunetN Tobacco smoking and intestinal metaplasia: systematic review and meta-analysis Dig Liver Dis 2014 46 1031 7 10.1016/j.dld.2014.08.034 Open DOISearch in Google Scholar

108. Thrift AP, Jove AG, Liu Y, Tan MC, El-Serag HB. Associations of duration, intensity, and quantity of smoking with risk of gastric intestinal metaplasia. J Clin Gastroenterol 2022; 56: e71–e6. doi: 10.1097/MCG.0000000000001479 ThriftAP JoveAG LiuY TanMC El-SeragHB Associations of duration, intensity, and quantity of smoking with risk of gastric intestinal metaplasia J Clin Gastroenterol 2022 56 e71 e6 10.1097/MCG.0000000000001479 Open DOISearch in Google Scholar

109. Mao Y, Yang W, Qi Q, Yu F, Wang T, Zhang H, et al. Blood groups A and AB are associated with increased gastric cancer risk: evidence from a large genetic study and systematic review. BMC Cancer 2019; 19: 164. doi: 10.1186/s12885-019-5355-4 MaoY YangW QiQ YuF WangT ZhangH Blood groups A and AB are associated with increased gastric cancer risk: evidence from a large genetic study and systematic review BMC Cancer 2019 19 164 10.1186/s12885-019-5355-4 Open DOISearch in Google Scholar

110. Rizzato C, Kato I, Plummer M, Muñoz N, Stein A, Jan van Doorn L, et al. Risk of advanced gastric precancerous lesions in Helicobacter pylori infected subjects is influenced by ABO blood group and cagA status. Int J Cancer 2013; 133: 315–22. doi: 10.1002/ijc.28019 RizzatoC KatoI PlummerM MuñozN SteinA Jan van DoornL Risk of advanced gastric precancerous lesions in Helicobacter pylori infected subjects is influenced by ABO blood group and cagA status Int J Cancer 2013 133 315 22 10.1002/ijc.28019 Open DOISearch in Google Scholar

111. Wang M, Lou E, Xue Z. The role of bile acid in intestinal metaplasia. Front Physiol 2023; 14: 1115250. doi: 10.3389/fphys.2023.1115250 WangM LouE XueZ The role of bile acid in intestinal metaplasia Front Physiol 2023 14 1115250 10.3389/fphys.2023.1115250 Open DOISearch in Google Scholar

112. Yu J, Zheng J, Qi J, Yang K, Wu Y, Wang K, et al. Bile acids promote gastric intestinal metaplasia by upregulating CDX2 and MUC2 expression via the FXR/NF-κB signalling pathway. Int J Oncol 2019; 54: 879–92. doi: 10.3892/ijo.2019.4692 YuJ ZhengJ QiJ YangK WuY WangK Bile acids promote gastric intestinal metaplasia by upregulating CDX2 and MUC2 expression via the FXR/NF-κB signalling pathway Int J Oncol 2019 54 879 92 10.3892/ijo.2019.4692 Open DOISearch in Google Scholar

113. Dias-Neto M, Pintalhao M, Ferreira M, Lunet N. Salt intake and risk of gastric intestinal metaplasia: systematic review and meta-analysis. Nutr Cancer 2010; 62: 133–47. doi: 10.1080/01635580903305391 Dias-NetoM PintalhaoM FerreiraM LunetN Salt intake and risk of gastric intestinal metaplasia: systematic review and meta-analysis Nutr Cancer 2010 62 133 47 10.1080/01635580903305391 Open DOISearch in Google Scholar

114. Song JH, Kim YS, Heo NJ, Lim JH, Yang SY, Chung GE, et al. high salt intake is associated with atrophic gastritis with intestinal metaplasia. Cancer Epidemiol Biomarkers Prev 2017; 26: 1133–8. doi: 10.1158/1055-9965.EPI-16-1024 SongJH KimYS HeoNJ LimJH YangSY ChungGE high salt intake is associated with atrophic gastritis with intestinal metaplasia Cancer Epidemiol Biomarkers Prev 2017 26 1133 8 10.1158/1055-9965.EPI-16-1024 Open DOISearch in Google Scholar

115. Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc 2008; 67: 253–6. doi: 10.1017/S002966510800712X WisemanM The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective Proc Nutr Soc 2008 67 253 6 10.1017/S002966510800712X Open DOISearch in Google Scholar

116. Jencks DS, Adam JD, Borum ML, Koh JM, Stephen S, Doman DB. Overview of current concepts in gastric intestinal metaplasia and gastric cancer. Gastroenterol Hepatol (N Y) 2018; 14: 92–101. PMID: 29606921 JencksDS AdamJD BorumML KohJM StephenS DomanDB Overview of current concepts in gastric intestinal metaplasia and gastric cancer Gastroenterol Hepatol (N Y) 2018 14 92 101 29606921 Search in Google Scholar